Healthcare -
Biotechnology - NASDAQ - US
$ 9.98
-6.73 %
$ 378 M
Market Cap
-3.56
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Celcuity Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 113 M |
| Operating Income | -113 M |
| Other Expenses | -1.49 M |
| Net Income | -112 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||||||||
| Cost Of Revenue | 0 | 0.1 | 0.2 | 0.3 | 0.4 | 0.3 | 0.2 | 0.1 | 73.1 K | 58.4 K |
| Gross Profit | 0 | (0.1) | (0.2) | (0.3) | (0.4) | (0.3) | (0.2) | (0.1) | 73.1 K | 58.4 K |
| OPERATING INCOME | ||||||||||
| Operating Expenses | 113.3 | 66.2 | 39.4 | 28.4 | 9.6 | 7.8 | 7.9 | 6.0 | 3.3 | 2.3 |
| Selling, General and Administrative Expenses | 9.1 | 5.6 | 4.1 | 2.6 | 1.9 | 1.5 | 1.6 | 1.0 | 0.3 | 0.3 |
| Research and Development Expenses | 104.2 | 60.6 | 35.3 | 25.8 | 7.7 | 6.3 | 6.3 | 5.0 | 3.1 | 2.0 |
| Operating Income | (113.3) | (66.2) | (39.4) | (28.4) | (9.6) | (7.8) | (7.9) | (6.0) | (3.3) | (2.3) |
| PRE-TAX INCOME | ||||||||||
| Interest Income Expense | (10.3) | 0 | 2.1 | 1.3 | 120 | 159 | 111 | 0.5 | 0 | 0 |
| Total Other Income | 1.5 | 2.5 | (1.0) | (1.2) | 82 K | 0.4 | 0.5 | (0.3) | 18 K | 268 |
| Pre-Tax Income | (111.8) | (63.8) | (40.4) | (29.6) | (9.5) | (7.4) | (7.5) | (6.3) | (3.3) | (2.3) |
| NET INCOME | ||||||||||
| Tax Provision | 0 | 0 | 1.0 | 1.0 | (0.4) | (0.3) | 0.5 | 48.2 K | 0 | 0 |
| Net Income | (111.8) | (63.8) | (41.3) | (30.6) | (9.1) | (7.0) | (7.5) | (6.3) | (3.3) | (2.3) |
| EPS | 2.83 | 2.69 | 2.68 | 2.28 | 0.89 | 0.69 | 0.74 | 0.84 | 0.49 | 0.36 |